JP2006511474A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2006511474A5 JP2006511474A5 JP2004537682A JP2004537682A JP2006511474A5 JP 2006511474 A5 JP2006511474 A5 JP 2006511474A5 JP 2004537682 A JP2004537682 A JP 2004537682A JP 2004537682 A JP2004537682 A JP 2004537682A JP 2006511474 A5 JP2006511474 A5 JP 2006511474A5
- Authority
- JP
- Japan
- Prior art keywords
- methyl
- phenoxy
- butylamino
- nicotinamide
- pyrazine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- ADXBHKREPBWTDP-UHFFFAOYSA-N CC(C)CCNCc(cc1)ccc1Oc(cc1)ncc1C(N)=O Chemical compound CC(C)CCNCc(cc1)ccc1Oc(cc1)ncc1C(N)=O ADXBHKREPBWTDP-UHFFFAOYSA-N 0.000 description 4
- QWNDOCKIKKQJNN-UHFFFAOYSA-N NC(c(cc1)cnc1Oc1ccc(CNCCC2CCOCC2)cc1F)=O Chemical compound NC(c(cc1)cnc1Oc1ccc(CNCCC2CCOCC2)cc1F)=O QWNDOCKIKKQJNN-UHFFFAOYSA-N 0.000 description 3
- WSTRRHWTLHPFLJ-UHFFFAOYSA-N CC(C)(C)CCNCc(cc1F)ccc1Oc1ncc(C(N)=O)nc1 Chemical compound CC(C)(C)CCNCc(cc1F)ccc1Oc1ncc(C(N)=O)nc1 WSTRRHWTLHPFLJ-UHFFFAOYSA-N 0.000 description 2
- QWVMKVCQRJKDNE-UHFFFAOYSA-N CC(C)CCNCc(c(F)c1F)cc(F)c1Oc(cc1)ncc1C(N)=O Chemical compound CC(C)CCNCc(c(F)c1F)cc(F)c1Oc(cc1)ncc1C(N)=O QWVMKVCQRJKDNE-UHFFFAOYSA-N 0.000 description 2
- KXIFIKGCMNZIRR-UHFFFAOYSA-N CCCCCNCc(cc1OC)ccc1Oc(nc1)cnc1C(N)=O Chemical compound CCCCCNCc(cc1OC)ccc1Oc(nc1)cnc1C(N)=O KXIFIKGCMNZIRR-UHFFFAOYSA-N 0.000 description 2
- ZGCYVRNZWGUXNQ-UHFFFAOYSA-N COc1cc(CNCCC2CCOCC2)ccc1Oc(nc1)cnc1C(N)=O Chemical compound COc1cc(CNCCC2CCOCC2)ccc1Oc(nc1)cnc1C(N)=O ZGCYVRNZWGUXNQ-UHFFFAOYSA-N 0.000 description 2
- ORJMHMIAJUKSME-UHFFFAOYSA-N COc1cc(CNCCc(cc2)ccc2F)ccc1Oc(nc1)cnc1C(N)=O Chemical compound COc1cc(CNCCc(cc2)ccc2F)ccc1Oc(nc1)cnc1C(N)=O ORJMHMIAJUKSME-UHFFFAOYSA-N 0.000 description 2
- SRTJWEAYPLHPFJ-UHFFFAOYSA-N CC(C)(C)CCCNCc(cc1OC)ccc1Oc(nc1)cnc1C(N)=O Chemical compound CC(C)(C)CCCNCc(cc1OC)ccc1Oc(nc1)cnc1C(N)=O SRTJWEAYPLHPFJ-UHFFFAOYSA-N 0.000 description 1
- MPAAEZPHTFLIIG-UHFFFAOYSA-N CC(C)(C)CCNCCc(cc1F)cc(F)c1Oc(nc1)ccc1C(N)=O Chemical compound CC(C)(C)CCNCCc(cc1F)cc(F)c1Oc(nc1)ccc1C(N)=O MPAAEZPHTFLIIG-UHFFFAOYSA-N 0.000 description 1
- RTJRBLXYTFNKGI-UHFFFAOYSA-N CC(C)(C)CCNCc(cc1)ccc1Oc(ccc(C(N)=O)c1)c1Cl Chemical compound CC(C)(C)CCNCc(cc1)ccc1Oc(ccc(C(N)=O)c1)c1Cl RTJRBLXYTFNKGI-UHFFFAOYSA-N 0.000 description 1
- WGCYEUMXKPHFPH-UHFFFAOYSA-N CC(C)(C)CCNCc(cc1F)cc(OC)c1Oc(cc1)ncc1C(N)=O Chemical compound CC(C)(C)CCNCc(cc1F)cc(OC)c1Oc(cc1)ncc1C(N)=O WGCYEUMXKPHFPH-UHFFFAOYSA-N 0.000 description 1
- MXOQKGNZONURBF-UHFFFAOYSA-N CC(C)CCNCc(cc1)ccc1Oc(c(F)cc(C(N)=O)c1)c1F Chemical compound CC(C)CCNCc(cc1)ccc1Oc(c(F)cc(C(N)=O)c1)c1F MXOQKGNZONURBF-UHFFFAOYSA-N 0.000 description 1
- IBNFHMRDGWKDCH-UHFFFAOYSA-N CC(C)CCNCc(cc1)ccc1Oc(ccc(C(N)=O)c1)c1F Chemical compound CC(C)CCNCc(cc1)ccc1Oc(ccc(C(N)=O)c1)c1F IBNFHMRDGWKDCH-UHFFFAOYSA-N 0.000 description 1
- HLCRMSMJGHCCGN-UHFFFAOYSA-N CC(C)CCNCc(cc1C)ccc1Oc(nc1)ccc1C(N)=O Chemical compound CC(C)CCNCc(cc1C)ccc1Oc(nc1)ccc1C(N)=O HLCRMSMJGHCCGN-UHFFFAOYSA-N 0.000 description 1
- WKJOLNYSGNKXFN-UHFFFAOYSA-N CC(C)CCNCc(cc1Cl)ccc1Oc(cc1)ncc1C(N)=O Chemical compound CC(C)CCNCc(cc1Cl)ccc1Oc(cc1)ncc1C(N)=O WKJOLNYSGNKXFN-UHFFFAOYSA-N 0.000 description 1
- DZZIJHPOQGYOHW-UHFFFAOYSA-N CC(C)CCNCc(cc1F)cc(F)c1Oc(cc1)ncc1C(N)=O Chemical compound CC(C)CCNCc(cc1F)cc(F)c1Oc(cc1)ncc1C(N)=O DZZIJHPOQGYOHW-UHFFFAOYSA-N 0.000 description 1
- KBJFPTRVYNXNLR-UHFFFAOYSA-N CC(C)CCNCc(cc1F)ccc1Oc(nc1)cnc1C(N)=O Chemical compound CC(C)CCNCc(cc1F)ccc1Oc(nc1)cnc1C(N)=O KBJFPTRVYNXNLR-UHFFFAOYSA-N 0.000 description 1
- COOCONHDRCJRDK-UHFFFAOYSA-N CCCCCNCc(c(F)c1F)ccc1Oc(nc1)ccc1C(N)=O Chemical compound CCCCCNCc(c(F)c1F)ccc1Oc(nc1)ccc1C(N)=O COOCONHDRCJRDK-UHFFFAOYSA-N 0.000 description 1
- NYFIRDWZRSBSFQ-UHFFFAOYSA-N CCCCCNCc(cc1F)ccc1Oc(nc1)cnc1C(N)=O Chemical compound CCCCCNCc(cc1F)ccc1Oc(nc1)cnc1C(N)=O NYFIRDWZRSBSFQ-UHFFFAOYSA-N 0.000 description 1
- IHCVJFPPZBMWNV-UHFFFAOYSA-N Cc(cc(CNCCC1CCOCC1)cc1)c1Oc(nc1)cnc1C(N)=O Chemical compound Cc(cc(CNCCC1CCOCC1)cc1)c1Oc(nc1)cnc1C(N)=O IHCVJFPPZBMWNV-UHFFFAOYSA-N 0.000 description 1
- ORWSVYPVMAOKOR-UHFFFAOYSA-N NC(c(cn1)ccc1Oc1ccc(CNCCC2CCOCC2)cc1)=O Chemical compound NC(c(cn1)ccc1Oc1ccc(CNCCC2CCOCC2)cc1)=O ORWSVYPVMAOKOR-UHFFFAOYSA-N 0.000 description 1
- FESNRGIEUHAIML-UHFFFAOYSA-N NC(c(cn1)ncc1Oc1ccc(CNCCC2CCOCC2)cc1F)=O Chemical compound NC(c(cn1)ncc1Oc1ccc(CNCCC2CCOCC2)cc1F)=O FESNRGIEUHAIML-UHFFFAOYSA-N 0.000 description 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US41215802P | 2002-09-19 | 2002-09-19 | |
| PCT/US2003/026300 WO2004026305A1 (en) | 2002-09-19 | 2003-09-17 | Diaryl ethers as opioid receptor antagonist |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2006511474A JP2006511474A (ja) | 2006-04-06 |
| JP2006511474A5 true JP2006511474A5 (https=) | 2006-10-19 |
| JP4646628B2 JP4646628B2 (ja) | 2011-03-09 |
Family
ID=32030816
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2004537682A Expired - Lifetime JP4646628B2 (ja) | 2002-09-19 | 2003-09-17 | オピオイド受容体アンタゴニストとしてのジアリールエーテル類 |
Country Status (29)
| Country | Link |
|---|---|
| US (3) | US7381719B2 (https=) |
| EP (2) | EP2208727B1 (https=) |
| JP (1) | JP4646628B2 (https=) |
| KR (1) | KR101025633B1 (https=) |
| CN (1) | CN1305852C (https=) |
| AR (1) | AR042423A1 (https=) |
| AT (1) | ATE395915T1 (https=) |
| AU (1) | AU2008246245B2 (https=) |
| BR (1) | BRPI0314308B8 (https=) |
| CA (1) | CA2499690C (https=) |
| CY (2) | CY1108228T1 (https=) |
| DE (1) | DE60321207D1 (https=) |
| DK (2) | DK2208727T3 (https=) |
| EA (1) | EA008861B1 (https=) |
| EC (1) | ECSP055684A (https=) |
| ES (2) | ES2305491T3 (https=) |
| HR (1) | HRP20050253B1 (https=) |
| MX (1) | MXPA05003093A (https=) |
| MY (1) | MY140236A (https=) |
| NO (1) | NO330740B1 (https=) |
| NZ (1) | NZ538459A (https=) |
| PE (1) | PE20050080A1 (https=) |
| PL (1) | PL212616B1 (https=) |
| PT (2) | PT1562595E (https=) |
| SI (2) | SI1562595T1 (https=) |
| TW (1) | TWI287012B (https=) |
| UA (1) | UA80437C2 (https=) |
| WO (1) | WO2004026305A1 (https=) |
| ZA (1) | ZA200502276B (https=) |
Families Citing this family (74)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6374762B1 (en) * | 1997-10-27 | 2002-04-23 | Correct Craft, Inc. | Water sport towing apparatus |
| US20030170917A1 (en) * | 2002-03-01 | 2003-09-11 | Roche Diagnostics Corporation | Compounds, antibodies, reagent kits, methods of producing antibodies, and methods of detecting analytes |
| KR101025633B1 (ko) * | 2002-09-19 | 2011-03-30 | 일라이 릴리 앤드 캄파니 | 오피오이드 수용체 안타고니스트로서의 디아릴 에테르 |
| GB0224557D0 (en) | 2002-10-22 | 2002-11-27 | Glaxo Group Ltd | Novel compounds |
| EP2133340B1 (en) | 2002-12-20 | 2013-01-16 | Glaxo Group Limited | Novel benzazepine derivatives |
| EP1613597B1 (en) | 2003-03-07 | 2007-11-07 | Eli Lilly and Company | 6-substituted nicotinamide derivatives as opioid receptor antagonists |
| CN1874991A (zh) | 2003-08-29 | 2006-12-06 | 小野药品工业株式会社 | 能够结合s1p受体的化合物及其药物用途 |
| EP1661881B1 (en) * | 2003-08-29 | 2014-12-17 | Ono Pharmaceutical Co., Ltd. | Compound capable of binding s1p receptor and pharmaceutical use thereof |
| CA2549009A1 (en) * | 2003-12-12 | 2005-07-07 | Eli Lilly And Company | Opioid receptor antagonists |
| ES2390459T3 (es) | 2003-12-22 | 2012-11-13 | Eli Lilly And Company | Antagonistas de receptores de opioides |
| JP4958560B2 (ja) | 2003-12-24 | 2012-06-20 | プロシディオン・リミテッド | Ｇｐｃｒ受容体作動薬としてのヘテロ環誘導体 |
| ATE399164T1 (de) | 2004-03-12 | 2008-07-15 | Lilly Co Eli | Antagonisten des opioidrezeptors |
| DE602005022572D1 (de) * | 2004-03-12 | 2010-09-09 | Lilly Co Eli | Antagonisten des opioidrezeptors |
| DE602005012380D1 (de) | 2004-03-15 | 2009-03-05 | Lilly Co Eli | 4-(5-(aminomethyl)-indol-1-ylmethyl)benzamidderivate und verwandte verbindungen als opioidrezeptorantagonisten zur behandlung von fettleibigkeit |
| EP1735268B1 (en) | 2004-03-15 | 2012-02-15 | Eli Lilly And Company | Opioid receptor antagonists |
| GB0408083D0 (en) * | 2004-04-08 | 2004-05-12 | Glaxo Group Ltd | Novel compounds |
| PE20060115A1 (es) | 2004-07-23 | 2006-03-23 | Basf Ag | 2-(piridin-2-il)-pirimidinas como agentes fungicidas |
| TW200621244A (en) | 2004-08-19 | 2006-07-01 | Vertex Pharma | Modulators of muscarinic receptors |
| US7786141B2 (en) | 2004-08-19 | 2010-08-31 | Vertex Pharmaceuticals Incorporated | Dihydrospiroindene modulators of muscarinic receptors |
| JP2008521825A (ja) * | 2004-11-29 | 2008-06-26 | バーテックス ファーマシューティカルズ インコーポレイテッド | ムスカリン受容体のモジュレーター |
| EP2592066B1 (en) * | 2004-12-13 | 2014-12-03 | Ono Pharmaceutical Co., Ltd. | Aminocarboxylic acid derivative and medical use thereof |
| EP2527337A1 (en) * | 2005-04-14 | 2012-11-28 | Bristol-Myers Squibb Company | Inhibitors of 11-beta hydroxysteroid dehydrogenase type I |
| US7939528B2 (en) | 2005-10-13 | 2011-05-10 | Glaxosmithkline Llc | Heterocycle compounds |
| CN101365682A (zh) | 2005-12-08 | 2009-02-11 | 千禧药品公司 | 具有激酶抑制活性的双环化合物 |
| AU2006329007A1 (en) * | 2005-12-20 | 2007-06-28 | Novartis Ag | Nicotinic acid derivatives as modulators of metabotropic glutamate receptors |
| US7858635B2 (en) * | 2005-12-22 | 2010-12-28 | Vertex Pharmaceuticals Incorporated | Spiro compounds as modulators of muscarinic receptors |
| WO2007079078A1 (en) | 2005-12-29 | 2007-07-12 | Bayer Schering Pharma Aktiengesellschaft | Diamine derivatives as inhibitors of leukotriene a4 hydrolase |
| CN101426499A (zh) | 2006-02-22 | 2009-05-06 | 弗特克斯药品有限公司 | 毒蕈碱受体调节剂 |
| NZ570497A (en) * | 2006-02-22 | 2011-09-30 | Vertex Pharma | Spiro condensed 4,4'-quinilino-piperidines derivatives as modulators of muscarinic receptors |
| CN103382174A (zh) | 2006-06-23 | 2013-11-06 | 雅培制药有限公司 | 作为组胺h3受体调节物的环丙胺衍生物 |
| US9108948B2 (en) | 2006-06-23 | 2015-08-18 | Abbvie Inc. | Cyclopropyl amine derivatives |
| CN101500565A (zh) * | 2006-06-29 | 2009-08-05 | 弗特克斯药品有限公司 | 毒蕈碱性受体的调节剂 |
| EP2054383A2 (en) * | 2006-08-09 | 2009-05-06 | SmithKline Beecham Corporation | Novel compounds as antagonists or inverse agonists at opioid receptors |
| EP2051712A2 (en) * | 2006-08-15 | 2009-04-29 | Vertex Pharmceuticals Incorporated | Modulators of muscarinic receptors |
| WO2008021545A2 (en) | 2006-08-18 | 2008-02-21 | Vertex Pharmaceuticals Incorporated | Modulators of muscarinic receptors |
| KR20090051778A (ko) * | 2006-09-08 | 2009-05-22 | 화이자 프로덕츠 인코포레이티드 | 다이아릴 에터 유도체 및 이의 용도 |
| MX2009004314A (es) * | 2006-11-13 | 2009-05-05 | Pfizer Prod Inc | Diaril, dipiridinil y arilpiridinilderivados y usos de los mismos. |
| US8093246B2 (en) * | 2006-12-14 | 2012-01-10 | Lexicon Pharmaceuticals, Inc. | O-linked pyrimidin-4-amine-based compounds, compositions comprising them, and methods of their use to treat cancer |
| IL180134A0 (en) * | 2006-12-17 | 2007-07-04 | David Ovadia | Process for the preparation of substituted cyanophenoxy-pyrimidinyloxy -phenyl acrylate derivatives |
| US20080186971A1 (en) * | 2007-02-02 | 2008-08-07 | Tarari, Inc. | Systems and methods for processing access control lists (acls) in network switches using regular expression matching logic |
| JP2010527980A (ja) * | 2007-05-22 | 2010-08-19 | プロシディオン・リミテッド | 代謝障害を治療するための二環状アリールおよびヘテロアリール化合物 |
| WO2009030962A1 (en) | 2007-09-07 | 2009-03-12 | Prosidion Limited | Bicyclic aryl and heteroaryl receptor modulators |
| EA201000316A1 (ru) * | 2007-09-12 | 2010-10-29 | ВАЙЕТ ЭлЭлСи | Производные изохинолинила и изоиндолинила в качестве антагонистов гистаминовых рецепторов 3 подтипа |
| MX2010003373A (es) * | 2007-10-03 | 2010-04-30 | Vertex Pharma | Moduladores de receptores muscarinicos. |
| JP5345637B2 (ja) * | 2008-01-22 | 2013-11-20 | イーライ リリー アンド カンパニー | κ選択的オピオイド受容体アンタゴニスト |
| WO2010067233A1 (en) | 2008-12-08 | 2010-06-17 | Pfizer Inc. | 1,2,4 triazolo [4, 3 -a] [1,5] benzodiazepin-5 (6h) -ones as agonists of the cholecystokinin-1 receptor (cck-ir) |
| US9186353B2 (en) | 2009-04-27 | 2015-11-17 | Abbvie Inc. | Treatment of osteoarthritis pain |
| AU2010295464B2 (en) * | 2009-09-18 | 2015-11-26 | Merck Sharp & Dohme Corp. | Use of opioid receptor antagonist for gastrointestinal tract disorders |
| WO2012064396A2 (en) | 2010-08-21 | 2012-05-18 | Georgetown University | Novel ezrin inhibitors and methods of making and using |
| US8853390B2 (en) | 2010-09-16 | 2014-10-07 | Abbvie Inc. | Processes for preparing 1,2-substituted cyclopropyl derivatives |
| WO2012075232A1 (en) * | 2010-12-04 | 2012-06-07 | Trevena, Inc. | Opioid receptor ligands and methods of using and making the same |
| ME02754B (me) | 2011-03-23 | 2018-01-20 | Trevena Inc | Ligandi opioidnih receptora i postupci njihove upotrebe i pripreme |
| GB201118876D0 (en) * | 2011-11-01 | 2011-12-14 | Astex Therapeutics Ltd | Pharmaceutical compounds |
| ES2631607T3 (es) * | 2011-12-09 | 2017-09-01 | Research Triangle Institute, International | 4-Arilpiperazinas 1-sustituidas como antagonistas del receptor opioide kappa |
| WO2013113720A1 (en) | 2012-02-03 | 2013-08-08 | Basf Se | Fungicidal pyrimidine compounds |
| JP2015511940A (ja) | 2012-02-03 | 2015-04-23 | ビーエーエスエフ ソシエタス・ヨーロピアＢａｓｆ Ｓｅ | 殺菌性ピリミジン化合物 |
| WO2013113787A1 (en) | 2012-02-03 | 2013-08-08 | Basf Se | Fungicidal pyrimidine compounds |
| WO2013113778A1 (en) | 2012-02-03 | 2013-08-08 | Basf Se | Fungicidal pyrimidine compounds |
| WO2014152536A2 (en) * | 2013-03-14 | 2014-09-25 | Celtaxsys, Inc. | Inhibitors of leukotriene a4 hydrolase |
| EP3389657A4 (en) | 2015-12-14 | 2019-08-07 | Trevena, Inc. | METHOD FOR THE TREATMENT OF HYPERALGESIA |
| CN106117190B (zh) * | 2016-06-21 | 2019-03-29 | 山东川成医药股份有限公司 | 一种倍福普兰的合成方法 |
| US10316021B2 (en) | 2016-11-28 | 2019-06-11 | Pfizer Inc. | Heteroarylphenoxy benzamide kappa opioid ligands |
| CN108299411B (zh) * | 2017-01-13 | 2021-02-05 | 中国人民解放军军事医学科学院毒物药物研究所 | 4,4-二苯基哌啶类化合物或其可药用盐、药物组合物及用途 |
| US11225487B2 (en) | 2017-02-17 | 2022-01-18 | Trevena, Inc. | 7-membered aza-heterocyclic containing δ-opioid receptor modulating compounds, methods of using and making the same |
| BR112019016827A2 (pt) | 2017-02-17 | 2020-04-07 | Trevena Inc | compostos moduladores de receptor delta-opioide contendo aza-heterocíclico com 5 membros, métodos de uso e produção dos mesmos |
| JP7234201B2 (ja) * | 2017-07-12 | 2023-03-07 | ブリストル－マイヤーズ スクイブ カンパニー | 心不全の治療のためのｒｏｃｋの５員アミノヘテロ環および５，６－または６，６員二環式アミノヘテロ環の阻害剤 |
| JP2021534215A (ja) * | 2018-08-24 | 2021-12-09 | ゼニオプロ ゲーエムベーハー | 病的症状の治療における使用のための芳香族分子 |
| FI4143183T3 (fi) | 2020-04-29 | 2026-01-07 | Gasherbrum Bio Inc | Heterosyklisiä glp-1-agonisteja |
| PE20231181A1 (es) | 2020-08-06 | 2023-08-11 | Gasherbrum Bio Inc | Agonistas del glp-1 heterociclicos |
| US12161622B2 (en) | 2021-05-04 | 2024-12-10 | Janssen Pharmaceuticals, Inc. | Compositions and methods for the treatment of depression |
| WO2023170550A1 (en) | 2022-03-07 | 2023-09-14 | Janssen Pharmaceuticals, Inc. | Polymorph forms of aticaprant for use in treating major depressive disorder |
| WO2023170554A1 (en) | 2022-03-07 | 2023-09-14 | Janssen Pharmaceuticals, Inc. | Compositions comprising aticaprant |
| WO2023179542A1 (en) * | 2022-03-21 | 2023-09-28 | Gasherbrum Bio , Inc. | 5,8-dihydro-1,7-naphthyridine derivatives as glp-1 agonists for the treatment of diabetes |
| WO2025122979A1 (en) * | 2023-12-07 | 2025-06-12 | Atai Therapeutics, Inc. | Compounds for serotonin receptor activation and pharmaceutical compositions and methods of using the same |
Family Cites Families (36)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4191771A (en) * | 1974-09-06 | 1980-03-04 | Eli Lilly And Company | Analgesic method using 1,3,4-trisubstituted-4-arylpiperidines |
| SE417011B (sv) * | 1979-03-05 | 1981-02-16 | Saab Scania Ab | Malanordning |
| US4346091A (en) * | 1980-05-27 | 1982-08-24 | Shell Oil Company | Insecticidal combinations |
| US4659089A (en) * | 1981-09-18 | 1987-04-21 | Tvi Energy Corporation | Multi-spectral target |
| US4546983A (en) * | 1981-09-18 | 1985-10-15 | Tvi Energy Corporation | Multi-spectral target |
| US4422646A (en) * | 1981-09-18 | 1983-12-27 | Tvi Energy Corporation | Infrared target for military applications and its use |
| US4891379A (en) * | 1987-04-16 | 1990-01-02 | Kabushiki Kaisha Kobe Seikosho | Piperidine opioid antagonists |
| CA1321792C (en) * | 1987-04-16 | 1993-08-31 | Eli Lilly And Company | Piperidine opioid antagonists |
| US4792142A (en) * | 1987-11-13 | 1988-12-20 | Davies Robert M | Thermal target device |
| US5065032A (en) * | 1990-09-10 | 1991-11-12 | Custom Training Aids | Thermal integrated target |
| US5319213A (en) * | 1992-04-06 | 1994-06-07 | The United States Of America As Represented By The Secretary Of The Army | Thermal target test board |
| ZA967892B (en) * | 1995-09-21 | 1998-03-18 | Lilly Co Eli | Selective β3 adrenergic agonists. |
| EP0827746B1 (en) * | 1996-09-05 | 2002-04-03 | Eli Lilly And Company | Carbazole analogues as selective beta3 adrenergic agonists |
| US5969369A (en) * | 1997-08-29 | 1999-10-19 | Fogarty; Charles M. | Infrared emissive module |
| CO5011072A1 (es) * | 1997-12-05 | 2001-02-28 | Lilly Co Eli | Etanolaminas pirazinil substituidas como agfonistas de los receptores |
| SE9802209D0 (sv) * | 1998-06-22 | 1998-06-22 | Astra Pharma Inc | Novel compounds |
| AUPP796798A0 (en) * | 1998-12-30 | 1999-01-28 | Fujisawa Pharmaceutical Co., Ltd. | New compound |
| US6436959B1 (en) * | 1998-12-23 | 2002-08-20 | Ortho-Mcneil Pharmaceutical, Inc. | 4-[aryl(piperidin-4-yl)]aminobenzamides |
| GB9828442D0 (en) * | 1998-12-24 | 1999-02-17 | Karobio Ab | Novel thyroid receptor ligands and method II |
| GB9912411D0 (en) | 1999-05-28 | 1999-07-28 | Pfizer Ltd | Compounds useful in therapy |
| US6337475B1 (en) * | 2000-02-24 | 2002-01-08 | The United States Of America As Represented By The Secretary Of The Army | Thermal silhouette target and zeroing technique |
| ES2398097T3 (es) * | 2000-07-13 | 2013-03-13 | Eli Lilly And Company | Agonistas adrenérgicos beta3 |
| EP1341759B1 (en) | 2000-11-10 | 2006-06-14 | Eli Lilly And Company | 3-substituted oxindole beta 3 agonists |
| US7507767B2 (en) * | 2001-02-08 | 2009-03-24 | Schering Corporation | Cannabinoid receptor ligands |
| DE60222396T2 (de) | 2001-03-29 | 2008-05-15 | Eli Lilly And Co., Indianapolis | N-(2-arylethyl) benzylamine als 5-ht6 rezeptor-antagoniste |
| GB0109103D0 (en) * | 2001-04-11 | 2001-05-30 | Pfizer Ltd | Novel compounds |
| KR101025633B1 (ko) * | 2002-09-19 | 2011-03-30 | 일라이 릴리 앤드 캄파니 | 오피오이드 수용체 안타고니스트로서의 디아릴 에테르 |
| EP1613597B1 (en) * | 2003-03-07 | 2007-11-07 | Eli Lilly and Company | 6-substituted nicotinamide derivatives as opioid receptor antagonists |
| ATE406360T1 (de) * | 2003-03-07 | 2008-09-15 | Lilly Co Eli | Antagonisten der opioidrezeptoren |
| US6767015B1 (en) * | 2003-06-05 | 2004-07-27 | The United States Of America As Represented By The Secretary Of The Navy | Thermal target |
| CA2549009A1 (en) * | 2003-12-12 | 2005-07-07 | Eli Lilly And Company | Opioid receptor antagonists |
| ES2390459T3 (es) * | 2003-12-22 | 2012-11-13 | Eli Lilly And Company | Antagonistas de receptores de opioides |
| ATE399164T1 (de) * | 2004-03-12 | 2008-07-15 | Lilly Co Eli | Antagonisten des opioidrezeptors |
| DE602005022572D1 (de) * | 2004-03-12 | 2010-09-09 | Lilly Co Eli | Antagonisten des opioidrezeptors |
| DE602005012380D1 (de) * | 2004-03-15 | 2009-03-05 | Lilly Co Eli | 4-(5-(aminomethyl)-indol-1-ylmethyl)benzamidderivate und verwandte verbindungen als opioidrezeptorantagonisten zur behandlung von fettleibigkeit |
| EP1735268B1 (en) * | 2004-03-15 | 2012-02-15 | Eli Lilly And Company | Opioid receptor antagonists |
-
2003
- 2003-09-17 KR KR1020057004628A patent/KR101025633B1/ko not_active Expired - Lifetime
- 2003-09-17 ES ES03751877T patent/ES2305491T3/es not_active Expired - Lifetime
- 2003-09-17 PL PL376057A patent/PL212616B1/pl unknown
- 2003-09-17 DK DK08153866.2T patent/DK2208727T3/da active
- 2003-09-17 MY MYPI20033546A patent/MY140236A/en unknown
- 2003-09-17 CN CNB038222418A patent/CN1305852C/zh not_active Expired - Lifetime
- 2003-09-17 SI SI200331282T patent/SI1562595T1/sl unknown
- 2003-09-17 SI SI200332196T patent/SI2208727T1/sl unknown
- 2003-09-17 HR HRP20050253AA patent/HRP20050253B1/hr not_active IP Right Cessation
- 2003-09-17 DE DE60321207T patent/DE60321207D1/de not_active Expired - Lifetime
- 2003-09-17 US US10/526,960 patent/US7381719B2/en not_active Expired - Lifetime
- 2003-09-17 EP EP08153866A patent/EP2208727B1/en not_active Expired - Lifetime
- 2003-09-17 WO PCT/US2003/026300 patent/WO2004026305A1/en not_active Ceased
- 2003-09-17 EP EP03751877A patent/EP1562595B1/en not_active Expired - Lifetime
- 2003-09-17 ES ES08153866T patent/ES2392200T3/es not_active Expired - Lifetime
- 2003-09-17 AT AT03751877T patent/ATE395915T1/de active
- 2003-09-17 PT PT03751877T patent/PT1562595E/pt unknown
- 2003-09-17 BR BRPI0314308A patent/BRPI0314308B8/pt not_active IP Right Cessation
- 2003-09-17 JP JP2004537682A patent/JP4646628B2/ja not_active Expired - Lifetime
- 2003-09-17 AR ARP030103376A patent/AR042423A1/es active IP Right Grant
- 2003-09-17 CA CA2499690A patent/CA2499690C/en not_active Expired - Lifetime
- 2003-09-17 DK DK03751877T patent/DK1562595T3/da active
- 2003-09-17 EA EA200500508A patent/EA008861B1/ru unknown
- 2003-09-17 MX MXPA05003093A patent/MXPA05003093A/es active IP Right Grant
- 2003-09-17 PT PT08153866T patent/PT2208727E/pt unknown
- 2003-09-17 NZ NZ538459A patent/NZ538459A/en not_active IP Right Cessation
- 2003-09-17 UA UAA200502384A patent/UA80437C2/uk unknown
- 2003-09-18 TW TW092125729A patent/TWI287012B/zh not_active IP Right Cessation
- 2003-09-18 PE PE2003000959A patent/PE20050080A1/es active IP Right Grant
-
2005
- 2005-03-17 ZA ZA200502276A patent/ZA200502276B/en unknown
- 2005-03-17 EC EC2005005684A patent/ECSP055684A/es unknown
- 2005-04-18 NO NO20051871A patent/NO330740B1/no not_active IP Right Cessation
-
2008
- 2008-03-21 US US12/052,972 patent/US7531557B2/en not_active Expired - Lifetime
- 2008-03-21 US US12/052,994 patent/US7560463B2/en not_active Expired - Lifetime
- 2008-07-30 CY CY20081100798T patent/CY1108228T1/el unknown
- 2008-11-19 AU AU2008246245A patent/AU2008246245B2/en not_active Expired
-
2012
- 2012-10-25 CY CY20121101016T patent/CY1113362T1/el unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2006511474A5 (https=) | ||
| CA2533598C (en) | Method for modulating calcium ion-release-activated calcium ion channels | |
| US11345676B2 (en) | Apoptosis signal-regulating kinase 1 (ASK 1) inhibitor compounds | |
| CA2299139A1 (en) | 4-phenyl-pyridine derivatives | |
| JP2004529931A5 (https=) | ||
| JP2010530432A5 (https=) | ||
| HRP20120029T1 (hr) | Derivati (4(4-[6-trifluorometil-piridin-3-ilamino)-n-sadržavajući-heteroaril]-fenil)-cikloheksil)-octene kiseline i njihove farmaceutske uporabe | |
| JP2004504301A5 (https=) | ||
| JP2008007519A5 (https=) | ||
| ZA200502276B (en) | Diaryl ethers as opioid receptor antagonist | |
| TW200815422A (en) | Heteroaryl derivatives as cytokine inhibitors | |
| JP2016534124A5 (https=) | ||
| JP2009516685A5 (https=) | ||
| RU2004135539A (ru) | Производные фенилалкановых кислот и фенилоксиалкановых кислот как активаторы hppar | |
| JP2006518763A5 (https=) | ||
| JP2009500443A5 (https=) | ||
| JP2004504400A5 (https=) | ||
| RU2012134093A (ru) | 4-фенокси-никотинамиды или 4-фенокси-пиримидин-5-карбоксамиды | |
| Hinklin et al. | Identification of a new class of glucokinase activators through structure-based design | |
| IL320810A (en) | Glucagon-like peptide 1 receptor agonists | |
| CN103102348A (zh) | 噁二唑类化合物及其制备方法、药物组合物及其用途 | |
| WO2010039236A1 (en) | Compounds for inflammation and immune-related uses | |
| CA2582276A1 (en) | Alkil-pyridines as 11-beta inhibitors for diabetes | |
| ME01851B (me) | Amidni derivati koji nose ciklopropilaminokarbonilni supstituent korisni kao inhibitori citokina | |
| CN101389610A (zh) | 作为香草素受体1(vr1)抑制剂的新苯并咪唑衍生物 |